Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

Image of people on a boat getting across large body of water in tropical area

Throughout February, March And April, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To Floating Doctors

SHOW YOUR SUPPORT - DONATE NOW

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

MicrobeTV Podcast

August 8, 2024

Long COVID Defined

View Updates

Person receiving a COVID-19 vaccine injection

August 1, 2024

Personal Protective Effect of Wearing Surgical Face Masks in Public Spaces on Self-reported Respiratory Symptoms in Adults | Cohort Study of Cardiovascular Safety of Different COVID-19 Vaccination Doses among 46 million Adults in England | Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years | Incidence of Diabetes after SARS-CoV-2 Infection in England | Post-COVID-19 Respiratory Sequelae Two Years after Hospitalization | Incidence of Hearing Loss Following COVID-19 among Young Adults in South Korea | The Effect of Long-term COVID-19 Infection on Maternal and Fetal Complications

View Updates

July 24, 2024

Insights from an N3C RECOVER EHR-based Cohort Study Characterizing SARS-CoV-2 Reinfections and Long COVID | Cost-effectiveness of COVID Rapid Diagnostic Tests for Patients with Severe/Critical Illness in Low- and Middle-income Countries: A Modeling Study | Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine | Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization in Adults With COVID-19 | Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection

View Updates

July 18, 2024

Post–Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 | Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for COVID-19 | Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity | Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19 | Comparative Effectiveness of Combination Therapy with Nirmatrelvir–ritonavir and Remdesivir versus Monotherapy with Remdesivir | Postacute Sequelae of SARS-CoV-2 Infection | The Efficacy of Antivirals, Corticosteroids, and mAbs as Acute COVID Treatments

View Updates

July 11, 2024

Proton Pump Inhibitors and Risk of COVID-19 Infection in Children | Long Covid The Answers

View Updates

July 4, 2024

Effectiveness and Safety of Molnupiravir in the Intended-Use Population: An Observational Cohort Study | The Life-saving Benefit of Dexamethasone in Severe COVID-19 is Linked to a Reversal of Monocyte Dysregulation | EEG Signatures of Cognitive Decline after Mild SARS-CoV-2 Infection: An Age-dependent Study | Tissue-based T Cell Activation and Viral RNA Persist for Up to 2 Years after SARS-CoV-2 Infection

View Updates